For years, we were taught to fear cholesterol. If a blood test showed our “bad” cholesterol was “high,” it was automatically bad news, and the solution was lifelong statins. Most of us were sold the idea that cholesterol was almost synonymous with heart disease, and that the lower it was, the better. “If you have high cholesterol, you can’t eat meat, say no to fats, take your daily statin, and don’t even think about eating eggs!” But today, functional medicine is showing that the real story is much more complex than a simple number on your lab report.

The first thing to understand is something very simple: cholesterol is not a “bad” substance. On the contrary, it is an essential raw material. The body needs it to produce hormones like estrogen, testosterone, and cortisol; to synthesize vitamin D; to form bile acids that help digest fats; to build the membranes of all our cells; and to maintain brain and nervous system function. In other words, without cholesterol, we couldn’t live. And most of the cholesterol in our body doesn’t even come from food—it is produced by the body itself.

So if cholesterol is so important, the right question is not “Is cholesterol good or bad?” but a much more useful one: in what context is that cholesterol circulating, and what is happening in the rest of the body? That’s where the entire diagnosis changes.

What is cholesterol?

It’s a type of lipid (a fatty substance) found in our blood. Since blood is mostly water, cholesterol cannot travel on its own. So the body transports it inside “particles” called lipoproteins.

There are mainly two types of these particles: LDL and HDL.

LDL (“bad” cholesterol): carries cholesterol from the liver to the rest of the body—delivering it where it’s needed.

HDL (“good” cholesterol): does the opposite. It collects excess cholesterol and brings it back to the liver for elimination.

The problem is that conventional medicine has focused for years on measuring a value called LDL-C, which is the amount of cholesterol inside LDL particles. If that number is high, it’s considered a risk.

But that number doesn’t tell the whole story.

LDL-C only measures how much cholesterol is inside those particles. It doesn’t tell us how many particles there are, how big they are, how easily they oxidize, how they behave in the body, or the metabolic environment in which they’re circulating.

And this matters a lot, because two people can have exactly the same LDL on paper, yet have very different cardiovascular risks.

It’s not just how much cholesterol you have: it’s how it travels

We’ve already said that cholesterol doesn’t float freely in the blood—it travels in “vehicles” called lipoproteins. But not all LDL particles are the same.

There are larger, less dense LDL particles, and there are smaller, denser ones. The latter tend to be more problematic, because they penetrate the arterial wall more easily, are more prone to oxidation, and usually appear in a metabolic environment with high triglycerides, inflammation, and insulin resistance. We can say that small, dense LDL particles are more atherogenic—that is, they have a greater capacity to contribute to plaque formation in the arteries compared to larger LDL particles.

That said, there’s an important nuance. While particle size matters, many experts now believe that the total number of atherogenic particles is even more important. In other words, it’s not enough to say “my particles are large, so I’m fine.” What’s most predictive is how many particles capable of entering the arterial wall are circulating overall. And this is where a key marker comes in: ApoB.

ApoB: the marker that better explains real risk

ApoB, or apolipoprotein B, is a protein present in each of the particles that can contribute to plaque formation, such as LDL, VLDL, IDL, and Lp(a). Simply put, each of these particles carries one ApoB.

That’s why measuring ApoB is a very useful way to understand how many potentially problematic particles are circulating in the blood. And this is key, because cardiovascular risk doesn’t depend only on how much cholesterol you have, but also on the size of the particles and how many of them are atherogenic.

In fact, there is growing evidence that ApoB can predict cardiovascular risk better than LDL-C and other traditional markers in many situations.

The real question: in what metabolic environment is that cholesterol?

Let’s go beyond the numbers. From a more holistic perspective, cholesterol is not interpreted as an isolated figure, but as part of a much broader network. What truly determines whether a lipid profile becomes dangerous is the context in which it exists: inflammation, blood sugar, insulin, liver, gut, thyroid, stress, sleep, body composition, and lifestyle.

Cholesterol becomes problematic when it circulates in an inflammatory and metabolically disrupted environment.

Inflammation: the key piece

Chronic low-grade inflammation is one of the major drivers of cardiovascular risk. It’s not always felt, and it doesn’t always produce obvious symptoms, but it creates an environment where lipid particles can cause damage. A very useful marker to assess it is high-sensitivity C-reactive protein (hs-CRP). The American College of Cardiology recognizes it as an important prognostic marker, and elevated levels are associated with higher cardiovascular risk.

Biology doesn’t work in separate compartments. The body functions as a perfectly synchronized and interconnected system—everything influences everything else.

Insulin resistance: one of the most overlooked causes

One of the most important—and least understood—factors when talking about cholesterol is insulin resistance. This means your body is not handling sugar properly, and to compensate, it produces more insulin.

When this happens, the body begins to lose its balance, especially in how it manages fats. The liver produces more triglycerides, fat-carrying particles (like VLDL) increase, and this ultimately favors the formation of a more problematic type of cholesterol: small, dense LDL particles, while HDL (the “good” one) decreases.

That’s why, many times, the issue is not cholesterol itself—it’s that your metabolism isn’t functioning properly.

A simple way to detect this is by looking at the triglyceride-to-HDL ratio:

Low triglycerides + high HDL → good metabolism

High triglycerides + low HDL → possible insulin resistance

It’s not a full diagnosis, but it’s a very useful clue that something deeper is going on.

Why can two people with the same cholesterol have very different risks?

This is something I think is incredibly important to explain well, because it helps break the obsession with a single number.

Imagine one person with relatively high LDL, but low ApoB, low triglycerides, good HDL, low insulin, low inflammation (low hs-CRP), a metabolically healthy weight, restorative sleep, good daily movement, and a healthy diet. Even if their LDL is somewhat high, their body is functioning well overall.

Now imagine a second person with the same LDL, but high ApoB, high triglycerides, low HDL, high inflammation (high hs-CRP), abdominal fat, poor sleep, and a dysregulated metabolism.

They both have the same LDL… but they do not have the same risk. The difference is not in the number, but in everything happening around it.

What tests to request if we truly want to understand risk

When someone wants to better understand their cardiovascular risk from a more complete perspective, it’s not enough to look only at total cholesterol, LDL, and HDL. A more refined approach usually includes an advanced lipoprotein panel, along with metabolic and inflammatory markers.

Among the most useful tests are ApoB, triglycerides, HDL, non-HDL cholesterol, Lp(a)—which many guidelines and experts recommend measuring at least once in a lifetime—fasting insulin, glucose, HbA1c, and hs-CRP. In some cases, it also makes sense to evaluate thyroid function and liver enzymes, since hypothyroidism and fatty liver can significantly alter the lipid profile.

This doesn’t mean everyone needs sophisticated testing indiscriminately, but it does mean that an intelligent interpretation of cholesterol requires more context than has traditionally been used.

The problem is when we stop asking deeper questions: does this person have inflammation? insulin resistance? poor sleep? chronic stress? do they eat ultra-processed foods? do they have hypothyroidism? is there a genetic component like high Lp(a)? is there fatty liver? how is their gut? is there exposure to smoking, excess alcohol, or environmental toxins? When these questions are not asked, we miss the full picture.

This changes everything, because it’s no longer about treating cholesterol as an isolated enemy, but about understanding the body as an integrated network. Inflammation affects blood vessels. Insulin resistance alters how the liver handles fats. Stress raises cortisol and disrupts metabolism. Poor sleep worsens insulin sensitivity. A sluggish thyroid worsens the lipid profile. The microbiome and the gut-liver axis influence the circulation and elimination of cholesterol and bile acids. When you start looking at it this way, you realize cholesterol is not the whole story—it’s just one scene in a much larger narrative.

What about diet?

When it comes to diet, it’s not fair to blame eggs, butter, or a fatty steak—it’s about the diet as a whole. Diets high in sugar, refined flours, ultra-processed foods, and excessive alcohol tend to raise triglycerides, lower HDL, and promote more atherogenic particles. But remember, it’s not only about the foods you choose, but also their quality.

That’s why, when someone truly improves their nutrition—eating real food rich in fiber, healthy fats, quality protein, plenty of vegetables, seeds, nuts, omega-3-rich fish—and also sleeps better, builds muscle, reduces inflammation, and corrects insulin resistance, they often improve not only their cholesterol “number,” but the entire metabolic pattern that was driving the problem. When you change your lifestyle is when real change truly happens.